Talcum Powder
Federal claims alleging that talc products caused ovarian cancer or mesothelioma are coordinated in New Jersey.
- Pending
- 68,914
- Federal district
- District of New Jersey
Federal mass tort intelligence
Court-sourced case counts, clearly labeled settlement status, and plain-English context—without the payout hype.
Numbers with provenanceEvery count links back to a dated source.
Estimates labeled honestlyProjections never masquerade as confirmed payouts.
Changes that mean somethingWe explain what moved, not just that it moved.
Largest active dockets
Ranked by actions currently pending in the JPML's August 3, 2026 report. Federal totals do not include every state-court or unfiled claim.
Federal claims alleging that talc products caused ovarian cancer or mesothelioma are coordinated in New Jersey.
Federal cases involving certain Bard and Davol polypropylene hernia mesh products are coordinated in Ohio.
The AFFF docket coordinates federal claims involving alleged exposure to PFAS-containing firefighting foam.
Federal lawsuits concerning certain hair relaxer products and alleged cancer risks are coordinated in Illinois.
The federal PPI docket coordinates claims involving certain heartburn medicines and alleged kidney injuries.
Federal claims involving Bair Hugger surgical warming devices and alleged infection risks are coordinated in Minnesota.
Why Settlement Advocate
Search results are crowded with unsupported payout ranges, recycled filing totals, and “latest” updates with no date. That makes it hard to tell what a court actually did from what someone expects it to do.
We separate verified events, reported allegations, and analysis. If an official settlement program does not exist, we say so plainly.
Read our editorial standardsResearch desk
Focused reports on court timelines, case-count movement, scientific evidence, labels, and what settlement documents actually establish.
Court timeline
A dated, source-led account of MDL 3140—from its February 2025 creation through the June 2026 global-agreement disclosure and the next scheduled expert-evidence hearing.
Docket data
Verified JPML snapshots for MDL 3140, with a plain-English explanation of pending versus historical actions and why docket growth cannot predict outcomes.
Settlement status
The court has confirmed a global agreement for some pending MDL plaintiffs. Its terms are not public, it will not resolve every case, and expert litigation is continuing.
Evidence review
A careful reading of the French national study, later U.S. research and the FDA label—without turning population associations into an individual diagnosis or legal conclusion.
FDA label history
What FDA-approved labels from 2010, 2024 and 2025 actually say—and why a label change is important without being a court finding of liability.
Court timeline
A dated guide to the federal gastrointestinal-injury proceeding, from the February 2024 transfer order to 2026 expert and summary-judgment scheduling.
Settlement literacy
Short, practical guides for understanding what legal headlines leave out.
MDL basics
How federal multidistrict litigation works, what it does not decide, and why an MDL case count is not the same as a settlement.
Read guideData literacy
What pending and historical action counts mean, what they leave out, and how to compare monthly federal MDL reports.
Read guideSettlement literacy
How settlement programs may value claims, why averages can deceive, and the warning signs of an unsupported payout estimate.
Read guideVerification guide
A five-source checklist for separating official settlement developments from recycled headlines and attorney advertising.
Read guide